Product Description
The global dental anesthetic market was valued at $1.3 billion in 2025. This is expected to increase over the forecast period at a CAGR of 5.8% to reach nearly $1.9 billion.
The full report suite on the global market for dental anesthetics is further segmented into the topical and local injection anesthetic markets. The units sold in the dental anesthetic market are defined in millions of milliliters, while the ASP represents the cost of one milliliter of a product.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Dental Anesthetics Market Trends
Growth in the dental anesthetic market is closely linked to rising dental procedure volumes, particularly restorative, surgical, and cosmetic treatments where local anesthesia is a clinical requirement rather than a discretionary choice. As patient expectations around comfort and pain control increase, the routine use of dental anesthetics has become deeply embedded across treatment pathways, reinforcing consistent demand across regions.
Dental Anesthetics Market Share Insights
- Septodont was the leading competitor in the global dental anesthetic market in 2025. The company offers a diverse array of anesthetic products, participating in the lidocaine, articaine, mepivacaine and bupivacaine drug categories. Several private-label companies use Septodont-owned Novocol’s anesthetic materials in their products. For these reasons, the market share of Septodont as a company is much larger than its market share for its own brand of local dental anesthetics.
- Dentsply Sirona acquired a notable market share of the dental anesthetics business in 2025. In addition to its local injection brands, such as Xylocaine® for lidocaine, Polocaine® for mepivacaine, Articadent® for articaine and Citanest® for prilocaine, Dentsply Sirona also carries Oraqix®, the periodontal gel composed of a combination of lidocaine and prilocaine. Oraqix® is a needle-free dental anesthetic specifically developed for scaling and root planing.
- Pierrel Pharma competed in the global dental anesthetic market with its Orabloc® injectable articaine product. Orabloc® is registered in major international markets, including the U.S., Canada, Italy, Russia, Poland, Serbia, France, the U.K., Germany, Kosovo, Austria, Sudan, Taiwan and Indonesia.
Dental Anesthetics Market Segmentation Summary
- Dental Anesthetic– Further Segmented Into:
- Product Type: Tropical, Local Injection
- Drug Type: Lidocaine, Articaine, Mepivacaine, Bupivacaine and Prilocaine
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
